Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Comment by smush74on Aug 22, 2013 8:48am
174 Views
Post# 21688833

RE:RE:RE:RE:RE:Cipher will recover and reach new highs as long as it keeps increasing profits every day and every quarter. Its always about the $$$

RE:RE:RE:RE:RE:Cipher will recover and reach new highs as long as it keeps increasing profits every day and every quarter. Its always about the $$$
truthseeker, your brokester comments are getting old, if you have proof or suspect it contact IIROC. People take profits live with it, I dropped 1/5 of my holdings which took care of my intial investment and some. I have stink bids of 7.16$ and 7 flat. One of my brokers is TD. So get over it, why people buy and sell at whatever levels should not be your concern it is their money. Same goes to a few other posters here. If you want to make projections back them up with facts. This board is quickly becoming a joke with pointless personal post. In box each other and leave the board alone. DND quarterly report will be in October, their have been no NR's since last one. No news we can try to extrapolate what is in our future that is it, nothing wrong, just bar the personal attacks.
Bullboard Posts